Stock·NYSE·Communication Services
Roblox Corp. (RBLX)
- Market cap
- $35.40B
- Dividend yield
- 0.00%
- Street target
- $47.00median of 35 analysts
- 52-week range
- $33.88 $135.85
The short version
Where RBLX stands today, in four lines, and what CleaRank Financial AI makes of it.
RBLX at a glance
Roblox Corp. (RBLX): Hold, 48/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 50-day but below its 200-day moving average ($43.47 and $53.65).
- Earnings RBLX beat estimates in 3 of its last 4 quarters, yet fell the next day after 1 of those beats.
- Insiders Insiders sold $937.7M and made no open-market purchases over the last 18 months.
Figures as of October 17, 2026.
CleaRank Financial AI
Roblox Corp. (RBLX) carries a CleaRank rating of Hold and a model score of 48/100.
The biggest lift comes from revenue growth, with revenue up 35.90%, 22.0 percentage points faster than the sector median. The biggest drag is valuation: RBLX has no meaningful P/E because it lost money, and its P/S of 6.21 is 148.4% above the sector median. The trend is mixed. The price trades 13.98% above its 50-day average of $43.47 but 7.65% below its 200-day average of $53.65. Over the past year, the price fell 63.16%.
Only on CleaRank
Figures we compute ourselves from RBLX's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
1/4Price above its 50-day average ›
The price of $49.55 is 14.0% above the 50-day simple moving average of $43.47.Price above its 200-day average ›
The price is 7.6% below the 200-day simple moving average of $53.65.50-day average above the 200-day ›
The 50-day average ($43.47) is 19.0% below the 200-day average ($53.65), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 15% of its 52-week range, between $33.88 and $135.85.
RBLX share price
Pick a period: each tab shows how far RBLX has moved over it, to the last close.
Today's trading
Where RBLX sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
1/3P/S below the sector median ›
The price-to-sales ratio of 6.21 is 148.2% above the sector median of 2.5.Profitable over the last 12 months ›
Net income over the last 12 months was $-1.0B on revenue of $5.7B, a net margin of -17.6%.Beat estimates in most recent reports ›
RBLX beat the EPS estimate in 3 of its last 4 reports.
Key statistics
The headline figures for RBLX.
As of October 17, 2026, RBLX trades at $49.55, with a market value of $35.40B and no P/E ratio (its trailing earnings are negative).
What the numbers say
CleaRank Financial AI's reading of RBLX's valuation, growth and risks.
Roblox Corp. (RBLX) cannot be valued on earnings, since its P/E is not meaningful: the company lost money over the last 12 months. Measured on sales, the price-to-sales ratio of 6.21 is 148.4% above the sector median of 2.5. Market capitalisation stands at $35.4B, and trailing earnings are -$1.42 a share.
RBLX is losing money: its net margin is -17.61% and its operating margin is -13.27%. On the top line, revenue grew 35.90% in the latest year, which is faster than the sector median of 13.9%. Return on equity stands at -432.28%, below the sector median of 15.8%. Debt-to-equity is 14.23.
RBLX reported on July 30, 2026 and beat the estimate by 21.21%, posting EPS of -$0.26 against the -$0.33 that analysts had expected. The share price nonetheless dropped 26.85% in the first session after the report.
Over its last 4 reports, RBLX topped the estimate 3 times, but beats have not guaranteed gains: the stock fell the next day after 1 of them. Earlier, the stock fell 9.26% after the July 31, 2025 report, a miss of 13.89%. The consensus EPS estimate stands at -$1.47 for this fiscal year and -$1.19 for next.
RBLX's average daily move is 4.33%. The price is 63.53% below its 52-week high of $135.85. Insiders sold $937.7M over the last 18 months and bought none on the open market, though sales of this kind are often planned in advance and say less than purchases would.
RBLX against the Communication Services sector
How RBLX compares with the median Communication Services stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, RBLX trades at 6.21x, +148% versus the sector average of 2.50x.
Return vs XLC: Since May 6, 2025, RBLX has lost 30.0% against a gain of 13.0% for XLC.
Performance against XLC
RBLX and the Communication Services sector fund over the same days.
Revenue and earnings
How much RBLX sells, and how much of it becomes profit.
Revenue growth: Revenue grew 35.8% in FY2025 to $4.9B, from $3.6B a year earlier.
Profit margin: The net margin was -21.9% in FY2025, up from -26.1% the year before.
Loss-making: RBLX lost $1.1B in FY2025.
Earnings reality check
Did RBLX beat what analysts expected, and how did the stock react?
Earnings record: RBLX beat the analyst estimate in 3 of the last 4 quarters.
Market reaction: The stock fell in the first session after 1 of those 3 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 30, 2026after close | -$0.33 | -$0.26 | +21.21% | -26.85% | -25.95% |
| Oct 30, 2025after close | -$0.50 | -$0.37 | +26.00% | +0.64% | -10.37% |
| Jul 31, 2025after close | -$0.36 | -$0.41 | -13.89% | -9.26% | -5.92% |
| May 1, 2025after close | -$0.40 | -$0.32 | +20.00% | +7.38% | +1.52% |
As of October 17, 2026, RBLX has beaten the analyst EPS estimate in 3 of its last 4 reported quarters and fell in the first trading session after 1 of those beats; its latest report, on July 30, 2026, came in 21.21% above the estimate and the stock moved -26.85% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 58.0, in neutral territory.RSI above 50 ›
An RSI of 58.0 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank AI analysis of RBLX
The score, the reasoning behind it, and what could move the price next.
Roblox Corp. (RBLX) shows a mixed trend. At $49.55, the stock sits 13.98% above its 50-day average of $43.47, yet 7.65% below its 200-day average of $53.65. Within its 52-week range the price is near the bottom: 46.25% above the low of $33.88, and 63.53% below the high of $135.85.
Recent gains sit against a weaker longer record: the price rose 4.47% over the past month, fell 4.12% over the past three months and fell 63.16% over the past year. Volume in the last session ran 41.8% below its average, on a day the price fell 3.09%. The 14-day RSI of 58.0 is in the neutral zone, and the MACD line is positive.
Earnings beat ›
The July 30, 2026 report beat the EPS estimate by 21.21%, and the share price fell 26.85% in the first session after it.
Source: Earnings report, July 30, 2026
Analyst downgrade ›
Jefferies downgraded it to Underperform from Hold on September 28, 2026.
Source: Analyst action, Jefferies, September 28, 2026
- The two levels closest to the price are the 200-day SMA at $53.65, which sits above it, and the 20-day EMA at $46.99, which sits below it.
- The 14-day RSI reads 58.0, which is neutral, and the MACD line is positive. Readings above 70 or below 30 point to stretched momentum.
- The share price fell 26.85% in the first session after the July 30, 2026 report. Over the last 4 reports, RBLX beat estimates in 3 of them.
The trend is mixed: RBLX is above its 50-day average at $43.47 but below its 200-day average at $53.65. A close above the 200-day would turn both signals up, and a close below the 50-day would turn both down. The nearest levels are the 20-day EMA at $46.99 below and the 200-day SMA at $53.65 above.
With a 14-day RSI of 58.0, the stock sits in the neutral zone, between 40 and 60.
Technical indicators
Momentum and trend for RBLX, from its daily closes.
As of October 17, 2026, with RBLX at $49.55, its 14-day RSI is 58.0 (neutral territory), its 50-day simple moving average is $43.47 and its 200-day is $53.65.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What RBLX moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, RBLX's 1-year correlation of daily returns is +0.31 with S&P 500 (SPY), +0.31 with Nasdaq 100 (QQQ), +0.24 with Bitcoin (BTC) and +0.13 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
0/3Most analysts rate it a buy ›
17 of 35 analysts rate it a buy or strong buy, 15 a hold and 3 a sell.Median target above the price ›
The median 12-month target of $47.00 is 5.1% below the price.More buy ratings than three months ago ›
17 of 35 rate it a buy now, against 20 of 34 three months ago.
RBLX Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Sep 28, 2026 | Jefferies | Downgrade | Underperform |
| Sep 23, 2026 | Needham | Maintains | Buy |
| Sep 15, 2026 | Macquarie | Maintains | Neutral |
| Sep 15, 2026 | Roth Capital | Maintains | Buy |
| Sep 15, 2026 | BTIG | Maintains | Sell |
| Sep 14, 2026 | Wells Fargo | Maintains | Overweight |
As of October 17, 2026, 35 Wall Street analysts cover RBLX: 17 rate it a buy or strong buy, 15 a hold and 3 a sell or strong sell. Their 12-month price targets range from $33.00 to $65.00, with a median of $47.00, 5.1% below the price of $49.55.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
RBLX trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
RBLX moves about 4.3% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much RBLX tends to move, against the market and on its own.
The long record
RBLX's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
1/4Average daily move under 2% ›
The price has moved 4.33% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 81.4%, from December 2021 to May 2022, regained by July 2025.Most 1-year holds ended higher ›
49% of 1-year holding periods in the last 6 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in March 2021 is now worth $7,129.50, against $21,146 in the S&P 500 (SPY).
RBLX Drawdowns & Recovery
As of October 17, 2026, RBLX's worst peak-to-trough fall over the last 6 years with dividends reinvested was -81.4% (December 2021 to May 2022); it regained that peak by July 2025, 38 months after the low, and 49% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into RBLX in March 2021 is worth now, against the same amount in the S&P 500.
Against the market: RBLX trailed the S&P 500 over this period: $7,129.50 against $21,146.
A $10,000 investment in RBLX in March 2021 would be worth about $7,130 today with dividends reinvested, compared with about $21,146 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to RBLX, and which have not.
Strongest month, October: an average of +8.58%, up in 3 of 5 years.
Weakest month, February: an average of -6.60%, up in 1 of 5 years.
This month, October: has averaged +8.58%, up in 3 of 5 years. Past seasonality does not repeat on schedule.
Over the last 6 years, RBLX's strongest calendar month has been October (average +8.58%, up in 3 of 5 years) and its weakest February (average -6.60%, up in 1 of 5 years).
Average return for each calendar month over the last 6 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in RBLX, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in RBLX today could grow to about $9,682 by 2036 in the base case, with a 90th-percentile outcome near $73,451 and a 10th-percentile outcome around $1,276. Projections are statistical simulations, not guarantees.
RBLX Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $48.91 for RBLX by 2030 in the base case, from $49.55 today (1.0x over 4 years). The 10th-percentile path ends near $13.58. These are outcomes of a Monte Carlo simulation run on RBLX's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $26.02 | $49.39 | $93.74 | |
| 2028 | $19.89 | $49.23 | $122 | |
| 2029 | $16.17 | $49.07 | $149 | |
| 2030 | $13.58 | $48.91 | $176 | |
| 2031 | $11.63 | $48.75 | $204 |
Method: a lognormal simulation of RBLX's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
RBLX insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought RBLX shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 17, 2026, RBLX insiders reported 118 open-market sales worth $937.7M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 5, 2026 | Mark Reinstra
Officer
|
Sell | 5.7K | $250.4K |
| Sep 8, 2026 | Mark Reinstra
Officer
|
Sell | 5.8K | $258.6K |
| Sep 1, 2026 | Gregory Baszucki
Director
|
Sell | 16.7K | $674.4K |
| Aug 31, 2026 | Andrea L Wong
Director
|
Sell | 562 | $23.0K |
| Aug 25, 2026 | Amy Marie Rawlings
Officer
|
Sell | 237 | $9.2K |
| Aug 24, 2026 | Sean Jack Buckley
Officer
|
Sell | 4.3K | $167.1K |
| Aug 20, 2026 | David Brent Baszucki
Chief Executive Officer
|
Sell | 52.6K | $2.0M |
| Aug 20, 2026 | Mark Reinstra
Officer
|
Sell | 17.9K | $680.8K |
| Aug 20, 2026 | Naveen Kumar Chopra
Chief Financial Officer
|
Sell | 17.5K | $664.7K |
| Aug 20, 2026 | Matthew D Kaufman
Officer
|
Sell | 14.9K | $565.8K |
| Aug 20, 2026 | Sean Jack Buckley
Officer
|
Sell | 5.6K | $212.9K |
| Aug 20, 2026 | Amy Marie Rawlings
Officer
|
Sell | 5.1K | $192.1K |
| Aug 19, 2026 | Mark Reinstra
Officer
|
Sell | 6.3K | $250.0K |
| Aug 10, 2026 | Anthony P Lee
Director
|
Grant | 100.0K | - |
| Aug 4, 2026 | Gregory Baszucki
Director
|
Sell | 16.7K | $624.4K |
| Jul 14, 2026 | Amy Marie Rawlings
Officer
|
Grant | 6.6K | - |
| Jul 6, 2026 | Mark Reinstra
Officer
|
Sell | 4.5K | $258.7K |
| Jul 1, 2026 | Gregory Baszucki
Director
|
Sell | 16.7K | $961.4K |
| Jun 15, 2026 | Amy Marie Rawlings
Officer
|
Grant | 32.3K | - |
| Jun 8, 2026 | Mark Reinstra
Officer
|
Sell | 6.0K | $249.3K |
| Jun 1, 2026 | Gregory Baszucki
Director
|
Sell | 16.7K | $777.1K |
| May 28, 2026 | Gregory Baszucki
Director
|
Grant | 5.2K | - |
| May 28, 2026 | Christopher Carvalho
Director
|
Grant | 5.2K | - |
| May 28, 2026 | Dennis M Durkin
Director
|
Grant | 5.2K | - |
| May 28, 2026 | Jason Kilar
Director
|
Grant | 5.2K | - |
| May 28, 2026 | Anthony P Lee
Director
|
Grant | 5.2K | - |
| May 28, 2026 | Gina Mastantuono
Director
|
Grant | 5.2K | - |
| May 28, 2026 | Andrea L Wong
Director
|
Grant | 5.2K | - |
| May 26, 2026 | Amy Marie Rawlings
Officer
|
Sell | 274 | $13.2K |
| May 22, 2026 | Sean Jack Buckley
Officer
|
Sell | 4.7K | $219.9K |
| May 21, 2026 | Mark Reinstra
Officer
|
Sell | 22.7K | $1.0M |
| May 20, 2026 | David Brent Baszucki
Chief Executive Officer
|
Sell | 50.6K | $2.3M |
| May 20, 2026 | Naveen Kumar Chopra
Chief Financial Officer
|
Sell | 16.9K | $763.6K |
| May 20, 2026 | Matthew D Kaufman
Officer
|
Sell | 14.4K | $650.0K |
| May 20, 2026 | Sean Jack Buckley
Officer
|
Sell | 5.7K | $256.5K |
| May 20, 2026 | Amy Marie Rawlings
Officer
|
Sell | 2.9K | $131.0K |
| May 5, 2026 | Gregory Baszucki
Director
|
Sell | 16.7K | $749.4K |
| Apr 17, 2026 | Amy Marie Rawlings
Officer
|
Grant | 5.2K | - |
| Apr 13, 2026 | Mark Reinstra
Officer
|
Sell | 18.7K | $1.1M |
| Apr 13, 2026 | Matthew D Kaufman
Officer
|
Sell | 13.3K | $772.1K |
| Apr 2, 2026 | David Brent Baszucki
Chief Executive Officer
|
Grant | 2.7M | - |
| Apr 1, 2026 | Gregory Baszucki
Director
|
Sell | 16.7K | $965.8K |
| Feb 27, 2026 | Gregory Baszucki
Director
|
Sell | 16.7K | $1.1M |
| Feb 27, 2026 | David Brent Baszucki
Chief Executive Officer
|
Grant | 102.3K | - |
| Feb 27, 2026 | Naveen Kumar Chopra
Chief Financial Officer
|
Grant | 73.3K | - |
| Feb 27, 2026 | Matthew D Kaufman
Officer
|
Grant | 85.6K | - |
| Feb 27, 2026 | Mark Reinstra
Officer
|
Grant | 96.8K | - |
| Feb 24, 2026 | Andrea L Wong
Director
|
Sell | 563 | $37.2K |
| Feb 20, 2026 | Arvind Chakravarthy
Officer
|
Sell | 21.4K | $1.3M |
| Feb 20, 2026 | Mark Reinstra
Officer
|
Sell | 17.2K | $1.1M |
| Feb 20, 2026 | Matthew D Kaufman
Officer
|
Sell | 15.2K | $937.9K |
| Feb 20, 2026 | Naveen Kumar Chopra
Chief Financial Officer
|
Sell | 12.7K | $783.3K |
| Feb 20, 2026 | David Brent Baszucki
Chief Executive Officer
|
Sell | 10.8K | $667.7K |
| Feb 20, 2026 | Amy Marie Rawlings
Officer
|
Sell | 3.0K | $181.7K |
| Feb 17, 2026 | Amy Marie Rawlings
Officer
|
Grant | 14.2K | - |
| Feb 13, 2026 | Mark Reinstra
Officer
|
Sell | 60.0K | $3.8M |
| Feb 11, 2026 | Arvind Chakravarthy
Officer
|
Sell | 95.9K | $6.6M |
| Feb 10, 2026 | David Brent Baszucki
Chief Executive Officer
|
Sell | 272.3K | $19.8M |
| Feb 10, 2026 | Mark Reinstra
Officer
|
Sell | 34.3K | $2.5M |
| Feb 10, 2026 | Matthew D Kaufman
Officer
|
Sell | 30.0K | $2.2M |
| Feb 9, 2026 | David Brent Baszucki
Chief Executive Officer
|
Grant | 893.1K | - |
| Feb 9, 2026 | Arvind Chakravarthy
Officer
|
Grant | 114.8K | - |
| Feb 9, 2026 | Matthew D Kaufman
Officer
|
Grant | 97.5K | - |
| Feb 9, 2026 | Mark Reinstra
Officer
|
Grant | 118.1K | - |
| Jan 16, 2026 | Amy Marie Rawlings
Officer
|
Grant | 3.4K | - |
| Jan 13, 2026 | Anthony P Lee
Director
|
Sell | 7.0K | $577.2K |
| Jan 7, 2026 | David Brent Baszucki
Chief Executive Officer
|
Sell | 66.9K | $5.1M |
| Jan 7, 2026 | David Brent Baszucki
Chief Executive Officer
|
Grant | 68.8K | - |
| Jan 2, 2026 | Anthony P Lee
Director
|
Sell | 59.0K | $4.7M |
| Dec 18, 2025 | David Brent Baszucki
Chief Executive Officer
|
Sell | 66.9K | $5.7M |
| Dec 18, 2025 | David Brent Baszucki
Chief Executive Officer
|
Grant | 68.8K | - |
| Dec 1, 2025 | Anthony P Lee
Director
|
Sell | 66.0K | $6.1M |
| Nov 21, 2025 | Anthony P Lee
Director
|
Grant | 80.0K | - |
| Nov 20, 2025 | Matthew D Kaufman
Officer
|
Sell | 20.9K | $2.0M |
| Nov 20, 2025 | Arvind Chakravarthy
Officer
|
Sell | 20.9K | $2.0M |
| Nov 20, 2025 | Naveen Kumar Chopra
Chief Financial Officer
|
Sell | 19.4K | $1.8M |
| Nov 20, 2025 | Mark Reinstra
Officer
|
Sell | 16.8K | $1.6M |
| Nov 20, 2025 | David Brent Baszucki
Chief Executive Officer
|
Sell | 10.6K | $1.0M |
| Nov 20, 2025 | Amy Marie Rawlings
Officer
|
Sell | 2.6K | $251.6K |
| Nov 11, 2025 | David Brent Baszucki
Chief Executive Officer
|
Sell | 66.9K | $7.0M |
| Nov 11, 2025 | David Brent Baszucki
Chief Executive Officer
|
Grant | 68.8K | - |
| Nov 6, 2025 | Matthew D Kaufman
Officer
|
Sell | 6.0K | $608.9K |
| Nov 5, 2025 | Mark Reinstra
Officer
|
Sell | 2.4K | $251.1K |
| Nov 5, 2025 | Gregory Baszucki
Director
|
Grant | 44.2K | - |
| Nov 4, 2025 | Anthony P Lee
Director
|
Sell | 66.0K | $6.9M |
| Nov 3, 2025 | Matthew D Kaufman
Officer
|
Sell | 6.0K | $677.9K |
| Oct 10, 2025 | Amy Marie Rawlings
Officer
|
Grant | 2.2K | - |
| Oct 2, 2025 | Matthew D Kaufman
Officer
|
Sell | 6.0K | $810.1K |
| Oct 1, 2025 | Anthony P Lee
Director
|
Sell | 66.0K | $9.0M |
| Sep 30, 2025 | Mark Reinstra
Officer
|
Grant | 16.0K | - |
| Sep 18, 2025 | Matthew D Kaufman
Officer
|
Sell | 6.0K | $819.3K |
| Sep 10, 2025 | Matthew D Kaufman
Officer
|
Grant | 9.6K | - |
| Sep 4, 2025 | Matthew D Kaufman
Officer
|
Sell | 6.0K | $805.2K |
| Sep 2, 2025 | Anthony P Lee
Director
|
Sell | 66.0K | $8.1M |
| Aug 21, 2025 | Matthew D Kaufman
Officer
|
Sell | 20.2K | $2.4M |
| Aug 20, 2025 | Manuel Bronstein
Officer
|
Sell | 22.4K | $2.7M |
| Aug 20, 2025 | Arvind Chakravarthy
Officer
|
Sell | 20.6K | $2.4M |
| Aug 20, 2025 | Mark Reinstra
Officer
|
Sell | 15.8K | $1.9M |
| Aug 20, 2025 | David Brent Baszucki
Chief Executive Officer
|
Sell | 10.4K | $1.2M |
| Aug 20, 2025 | Amy Marie Rawlings
Officer
|
Sell | 6.6K | $773.0K |
| Aug 14, 2025 | David Brent Baszucki
Chief Executive Officer
|
Grant | 150.0K | - |
| Aug 7, 2025 | Matthew D Kaufman
Officer
|
Sell | 6.0K | $802.0K |
| Aug 7, 2025 | David Brent Baszucki
Chief Executive Officer
|
Grant | 1.1M | - |
| Aug 7, 2025 | Anthony P Lee
Director
|
Grant | 50.0K | - |
| Aug 5, 2025 | Anthony P Lee
Director
|
Sell | 177.1K | $23.1M |
| Aug 5, 2025 | David Brent Baszucki
Chief Executive Officer
|
Sell | 875 | $110.9K |
| Aug 5, 2025 | Mark Reinstra
Officer
|
Grant | 2.5K | - |
| Aug 4, 2025 | Andrea L Wong
Director
|
Sell | 5.8K | $752.4K |
| Jul 17, 2025 | Matthew D Kaufman
Officer
|
Sell | 6.0K | $711.1K |
| Jul 15, 2025 | Naveen Kumar Chopra
Chief Financial Officer
|
Grant | 356.5K | - |
| Jul 15, 2025 | Amy Marie Rawlings
Officer
|
Grant | 3.0K | - |
| Jul 3, 2025 | Matthew D Kaufman
Officer
|
Sell | 6.0K | $615.5K |
| Jul 1, 2025 | Anthony P Lee
Director
|
Sell | 66.0K | $6.9M |
| Jun 26, 2025 | David Brent Baszucki
Chief Executive Officer
|
Sell | 167.4K | $17.6M |
| Jun 26, 2025 | David Brent Baszucki
Chief Executive Officer
|
Grant | 41.9K | - |
| Jun 25, 2025 | David Brent Baszucki
Chief Executive Officer
|
Sell | 288.7K | $30.3M |
| Jun 25, 2025 | David Brent Baszucki
Chief Executive Officer
|
Grant | 72.2K | - |
| Jun 25, 2025 | David Brent Baszucki
Chief Executive Officer
|
Option | 240.5K | $819.1K |
| Jun 20, 2025 | Matthew D Kaufman
Officer
|
Sell | 6.0K | $620.1K |
| Jun 17, 2025 | David Brent Baszucki
Chief Executive Officer
|
Sell | 628.7K | $63.2M |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.